Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is JSP Pharmaceutical Manufacturing (Thailand) PCL Dividend Yield %?
JSP Pharmaceutical Manufacturing (Thailand) PCLBKK:JSP 80 Dividend Yield % is 5.62% as of Jul. 16, 2026, which is 233% above its 10-year median of 1.69. GuruFocus rates BKK:JSP with a GF Score™ of 80/100 and a GF Value™ of ฿3.16 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 1,170 Consumer Packaged Goods companies, JSP Pharmaceutical Manufacturing (Thailand) PCL ranks better than 82.22% on this metric.
BKK:JSP's Dividend Yield % is ranked better than 82.22% of 1170
companies
in the Consumer Packaged Goods industry
Industry Median: 2.845
vs BKK:JSP: 5.62
During the past 12 months, JSP Pharmaceutical Manufacturing (Thailand) PCL's average Dividends Per Share Growth Rate was 65.60% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 59.80% per year.
During the past 7 years, the highest 3-Year average Dividends Per Share Growth Rate of JSP Pharmaceutical Manufacturing (Thailand) PCL was 59.80% per year. The lowest was 59.80% per year. And the median was 59.80% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, JSP Pharmaceutical Manufacturing (Thailand) PCL's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JSP Pharmaceutical Manufacturing (Thailand) PCL Dividend Yield % vs Consumer Packaged Goods Industry
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
JSP Pharmaceutical Manufacturing (Thailand) PCL Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
THB 0.047400
2026-04-28
2026-04-29
2026-05-15
Cash Dividend
semi-annually
THB:THB 1.000000
THB 0.052600
2025-08-26
2025-08-27
2025-09-12
Cash Dividend
semi-annually
THB:THB 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP) has a Dividend Yield % of 5.62% as of Jul. 16, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on JSP Pharmaceutical Manufacturing (Thailand) PCL and its competitors. This is 233% above median its historical median of 1.69. Over the past decade, JSP Pharmaceutical Manufacturing (Thailand) PCL's Dividend Yield % has ranged from 0.27 to 5.65. According to the industry distribution chart, JSP Pharmaceutical Manufacturing (Thailand) PCL ranks #208 out of 1170 companies in the Consumer Packaged Goods industry, placing it in the top 17.8%.
Is JSP Pharmaceutical Manufacturing (Thailand) PCL's Dividend Yield % too high?
JSP Pharmaceutical Manufacturing (Thailand) PCL's current Dividend Yield % of 5.62% is 233% above median its 10-year median of 1.69. Over the past 10 years, this metric has ranged from a low of 0.27 to a high of 5.65. The Consumer Packaged Goods industry median Dividend Yield % is 2.85. JSP Pharmaceutical Manufacturing (Thailand) PCL's value of 5.62% is 97.5% above this industry median. Based on the distribution chart, JSP Pharmaceutical Manufacturing (Thailand) PCL ranks #208 out of 1170 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, JSP Pharmaceutical Manufacturing (Thailand) PCL has a GF Score™ of 80/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does JSP Pharmaceutical Manufacturing (Thailand) PCL's Dividend Yield % compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, JSP Pharmaceutical Manufacturing (Thailand) PCL ranks #208 out of 1170 companies for Dividend Yield %. This places JSP Pharmaceutical Manufacturing (Thailand) PCL in the top 18% of its industry — outperforming the majority of peers. The industry median Dividend Yield % is 2.85. JSP Pharmaceutical Manufacturing (Thailand) PCL's value of 5.62% is 97.5% above this benchmark. Historically, JSP Pharmaceutical Manufacturing (Thailand) PCL's own Dividend Yield % has ranged from 0.27 to 5.65 over the past decade. While the company's 10-year median is 1.69 vs. the industry median of 2.85, JSP Pharmaceutical Manufacturing (Thailand) PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Consumer Packaged Goods company?
The median Dividend Yield % among Consumer Packaged Goods companies is 2.85, based on 1,170 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. JSP Pharmaceutical Manufacturing (Thailand) PCL's current Dividend Yield % of 5.62% is 97.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on JSP Pharmaceutical Manufacturing (Thailand) PCL and its competitors. For the Consumer Packaged Goods industry, the median Dividend Yield % is 2.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JSP Pharmaceutical Manufacturing (Thailand) PCL's current Dividend Yield % is 5.62%, which is 233% above median its own 10-year median of 1.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JSP Pharmaceutical Manufacturing (Thailand) PCL stock overvalued right now?
Based on GuruFocus' analysis, JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP) is currently considered Significantly Undervalued. The stock's GF Value™ is ฿3.16, compared to a current price of ฿1.78 — trading 43.7% below its estimated fair value. The current Dividend Yield % is 5.62%, which is 233% above median its 10-year median of 1.69 and 97.5% above the Consumer Packaged Goods industry median of 2.85. JSP Pharmaceutical Manufacturing (Thailand) PCL's overall GF Score™ is 80/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP), the current Dividend Yield % is 5.62% as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP) Overvalued in 2026?
Based on GuruFocus' analysis, JSP Pharmaceutical Manufacturing (Thailand) PCL stock appears to be undervalued.
The current stock price of ฿1.78 is trading 43.7% below its estimated GF Value™ of ฿3.16.
GuruFocus considers JSP Pharmaceutical Manufacturing (Thailand) PCL to be Significantly Undervalued.
Key valuation signals for BKK:JSP:
Dividend Yield %: 5.62% (233% above median its 10-year median of 1.69)
GF Value™: ฿3.16 vs. price of ฿1.78 (43.7% below fair value)
Industry Position: 97.5% above the Consumer Packaged Goods median (#208 of 1170)
No single metric tells the full story. See the BKK:JSP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
JSP Pharmaceutical Manufacturing (Thailand) PCL Business Description
JSP Pharmaceutical Manufacturing (Thailand) PCL is engaged in producing modern medicine, traditional medicine, herbal products, dietary supplements, medical supplies, and cleaning alcohol under the client's and the company's own trademarks. Maximum revenue for the company is generated from the sale of dietary supplements. The Group's reportable operating segments are: Manufacture and distribution of products under the company's brand name (Own brands), which generate maximum revenue, Manufacture and distribution of products under customers' brand name (OEM), Manufacture and distribution of hemodialysis solution and related medical supplies; and Service, research and development, and healthcare products training. Geographically, it operates principally in Thailand.
80GF Score
Get the complete analysis for BKK:JSP
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:JSP has been successfully added to your 
